|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.400 USD | +1.27% |
|
-0.41% | +33.33% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.27% | -0.41% | +4.35% | +11.11% | +33.33% | +58.94% | +43.71% | +54.84% | -63.64% | 193M | |
| +0.13% | +4.41% | -0.88% | +37.92% | +11.43% | +47.35% | +163.20% | +391.64% | +1,335.89% | 1,068B | |
| +0.97% | +6.88% | +4.43% | +18.02% | +28.51% | +58.02% | +53.12% | +54.03% | +113.15% | 641B | |
| -0.94% | +1.39% | +1.41% | +30.16% | +12.44% | +35.02% | +72.60% | +117.79% | +295.86% | 454B | |
| +0.43% | +8.36% | +6.76% | +12.64% | +10.21% | +38.80% | +34.26% | +4.06% | +47.33% | 351B | |
| +0.46% | +2.82% | +2.28% | +12.52% | +17.77% | +38.29% | +43.02% | +53.70% | +60.75% | 299B | |
| -0.64% | +2.55% | -10.41% | -7.84% | -7.11% | +18.72% | +15.84% | +54.97% | +154.82% | 266B | |
| +0.69% | +1.39% | +4.33% | +23.91% | +1.01% | -27.17% | -37.82% | +14.32% | +73.88% | 220B | |
| +0.06% | +3.32% | +5.00% | +10.61% | +14.96% | +22.73% | +59.40% | +53.78% | +120.45% | 203B | |
| +0.94% | -2.02% | +2.06% | +2.17% | +6.34% | +12.32% | +70.59% | +89.35% | +59.58% | 162B | |
| +0.53% | -0.32% | +1.56% | -7.91% | -0.92% | -0.48% | -31.85% | -41.40% | -33.05% | 141B | |
| +0.76% | +3.99% | +8.76% | +8.27% | +15.98% | +29.18% | +3.01% | -7.30% | -18.19% | 128B | |
| +0.34% | -0.31% | -2.51% | +12.44% | +5.66% | +1.99% | +37.00% | +136.14% | +398.91% | 122B | |
| +1.08% | +2.35% | +4.04% | -0.43% | -5.04% | -8.13% | -17.28% | -10.32% | +2.96% | 106B | |
| +1.56% | +5.81% | +1.19% | -1.23% | +9.78% | +43.28% | +44.83% | +14.33% | -5.71% | 104B | |
| +2.21% | -5.38% | -7.59% | -11.85% | -15.09% | -5.79% | +69.63% | +70.71% | +443.26% | 68.84B | |
| -0.43% | +3.40% | +10.97% | +8.60% | +18.80% | +33.43% | +32.84% | +55.24% | +26.72% | 56.28B | |
| -0.80% | -1.53% | +1.87% | +28.04% | +26.70% | +61.94% | -10.52% | -7.19% | -50.28% | 52.78B | |
| +0.28% | -3.55% | +10.13% | -3.21% | -10.02% | -4.96% | +11.41% | -1.65% | +234.93% | 52.23B | |
| +2.19% | +2.79% | +8.75% | +8.01% | +1.09% | +4.09% | +12.43% | - | - | 43.39B | |
| Average | +0.84% | +1.30% | +2.83% | +9.60% | +8.79% | +22.88% | +33.47% | +57.74% | +168.30% | 226.86B | |
| Weighted average by Cap. | +1.04% | +2.36% | +1.72% | +18.12% | +11.34% | +32.30% | +65.24% | +130.10% | +410.01% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
